We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type


Firm name


280 results found


Mayer Brown | USA | 29 Jul 2010

Corporate whistleblower protections significantly altered by Dodd-Frank Wall Street Reform Act

The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") includes important changes to corporate whistleblower protections that affect publicly traded and non-publicly traded companies.


Arent Fox LLP | USA | 20 Jul 2010

Fueling the FCPA fire: the Dodd-Frank Act whistleblower provisions

The Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) is expected to be signed into law by the President this week.


Kramer Levin Naftalis & Frankel LLP | USA | 19 Jul 2010

Dodd-Frank’s impact on securities litigation and enforcement

On July 15, 2010, the United States Senate voted to approve the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank”), one of the most wide-ranging legislative efforts at financial reform since the Great Depression.


Gibson Dunn & Crutcher LLP | USA | 29 Apr 2010

U.S. Supreme Court extends time to file federal securities fraud suits

On April 27, 2010, the United States Supreme Court held that the statute of limitations for private actions claiming securities fraud under Section 10(b) of the Securities Exchange Act of 1934 does not begin to run until plaintiffs have discovered or, with reasonable diligence, could have discovered the facts constituting the fraud, including scienter.


Schulte Roth & Zabel LLP | USA | 8 Feb 2010

Enforcement and litigation cases to watch in 2010

By all accounts, 2010 promises more noteworthy developments in the securities enforcement and litigation area.


Locke Lord LLP | USA | 8 Jun 2009

U.S. Supreme Court to decide "inquiry notice" standard

On May 26, 2009, the U.S. Supreme Court granted Merck's petition for a writ of certiorari in the securities class action regarding Merck's Vioxx disclosures.

Previous page 1 2 3 ...